当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析 - 资产负债表

瑞普生物

(300119)

  

流通市值:55.08亿  总市值:75.62亿
流通股本:3.39亿   总股本:4.65亿

资产负债表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
流动资产:
  货币资金413,672,083.14531,537,248.99568,317,746.66651,187,038.58
  交易性金融资产1,075,349,003.321,021,719,559.041,113,158,780.071,042,700,118.27
  应收票据及应收账款1,229,569,931.831,182,274,565.241,120,721,218.551,009,525,204.1
  其中:应收票据16,812,066.1716,921,277.5420,014,438.2925,925,814.21
        应收账款1,212,757,865.661,165,353,287.71,100,706,780.26983,599,389.89
  应收款项融资5,681,305.534,268,548.959,446,693.078,322,771.9
  预付款项108,264,610.4992,899,791.1284,837,689.7371,341,123.25
  其他应收款合计94,131,188.9782,742,816.0792,907,989.9872,556,976.85
  存货522,216,462.87495,037,126.39521,705,345.38502,117,273.6
  其他流动资产102,812,937.4921,230,371.5624,129,465.4516,852,862.54
  流动资产合计3,551,697,523.643,431,710,027.363,535,224,928.893,374,603,369.09
非流动资产:
  长期应收款1,133,921.091,267,873.391,344,884.461,491,357.8
  长期股权投资1,343,559,299.941,465,134,483.551,349,526,868.061,347,828,101.32
  其他非流动金融资产48,579,410.3647,033,572.8749,066,551.6353,349,733.37
  投资性房地产30,475,530.8831,473,757.9632,471,985.0133,470,212.09
  固定资产1,795,254,789.211,562,907,755.11,585,599,739.531,619,177,205.22
  在建工程156,786,822.5881,273,322.3562,250,720.3631,889,731.39
  使用权资产9,626,591.256,758,720.315,936,585.288,356,783.66
  无形资产481,411,725.88467,534,274.22470,874,505.29484,053,690.53
  开发支出214,852,156.83199,614,788.15203,577,248.22197,044,437.22
  商誉528,263,846.37445,689,818.37442,989,818.37442,989,818.37
  长期待摊费用1,780,941.821,400,369.811,417,614.11,397,684.25
  递延所得税资产40,064,705.4537,985,122.4537,070,738.5536,947,810.04
  其他非流动资产32,180,357.2831,212,991.4324,972,829.7623,309,774.27
  非流动资产合计4,683,970,098.944,379,286,849.964,267,100,088.624,281,306,339.53
  资产总计8,235,667,622.587,810,996,877.327,802,325,017.517,655,909,708.62
流动负债:
  短期借款1,128,056,623.021,109,992,219.53860,927,049.84785,593,744.31
  应付票据及应付账款562,896,794.08527,364,253.14480,319,251.05436,830,223.47
  其中:应付票据202,136,011.05192,848,632149,875,869.86100,810,918.14
        应付账款360,760,783.03334,515,621.14330,443,381.19336,019,305.33
  预收款项35,062.956,791.07129,358.23101,592.77
  合同负债49,825,615.2947,529,379.6259,675,653.7572,656,719.45
  应付职工薪酬36,758,612.1137,488,927.8434,607,839.9352,322,917.68
  应交税费58,292,894.8637,757,161.145,148,764.2930,046,426.58
  其他应付款合计226,487,093.81188,462,293.13146,354,125.18180,531,315.13
  其中:应付利息22,065.529,491.37--
        应付股利13,750,924.4721,047,00029,750,000-
  一年内到期的非流动负债254,334,392.1157,604,450.56302,232,241.31303,719,284.91
  其他流动负债21,785,468.1417,969,864.8928,986,108.0127,804,836.6
  流动负债合计2,338,472,556.312,124,225,340.881,958,380,391.591,889,607,060.9
非流动负债:
  长期借款231,760,060344,787,196.2360,355,900368,423,036.2
  租赁负债6,526,583.034,058,787.353,875,078.042,584,702.58
  递延收益243,988,066.8397,896,043.1991,015,597.4592,655,861.28
  递延所得税负债110,764,351.27115,984,746.89117,048,747.15118,015,598.77
  非流动负债合计593,039,061.13562,726,773.63572,295,322.64581,679,198.83
  负债合计2,931,511,617.442,686,952,114.512,530,675,714.232,471,286,259.73
所有者权益(或股东权益):
  实收资本(或股本)464,754,706464,754,706464,754,706464,754,706
  资本公积2,117,772,721.962,125,296,525.882,144,673,763.432,144,673,763.43
  减:库存股191,211,941.65191,211,941.65191,211,941.65191,211,941.65
  其他综合收益45,528.7345,528.7345,528.7345,528.73
  盈余公积232,923,953232,923,953232,923,953232,923,953
  未分配利润2,169,114,901.292,074,375,478.482,159,675,210.162,051,896,990.9
  归属于母公司股东权益合计4,793,399,869.334,706,184,250.444,810,861,219.674,703,083,000.41
  少数股东权益510,756,135.81417,860,512.37460,788,083.61481,540,448.48
  股东权益合计5,304,156,005.145,124,044,762.815,271,649,303.285,184,623,448.89
  负债和股东权益合计8,235,667,622.587,810,996,877.327,802,325,017.517,655,909,708.62
公告日期2026-10-282026-08-262026-04-282026-03-31
审计意见(境内)标准无保留意见
TOP↑